Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology and Child Health
Reference4 articles.
1. Wong W (2021) Shiga toxin producing Escherichia coli infections and associated haemolytic uraemic syndrome in New Zealand children: twenty three years of epidemiology and clinical observations. Int J Pediatr Res 8:085
2. Wildes DM, Harvey S, Costigan CS, Sweeney C, Twomey É, Awan A et al (2023) Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement. Pediatr Nephrol. https://doi.org/10.1007/s00467-023-06102-w
3. Pape L, Hartmann H, Bange FC, Suerbaum S, Bueltmann E, Ahlenstiel-Grunow T (20215) Eculizumab in typical hemolytic uremic syndrome (HUS) with neurological involvement. Medicine (Baltimore) 94:e1000
4. Giordano P, Netti GS, Santangelo L, Castellano G, Carbone V, Torres DD et al (2019) A pediatric neurologic assessment score may drive the eculizumab-based treatment of Escherichia coli-related hemolytic uremic syndrome with neurological involvement. Pediatr Nephrol 34:517–527